HB 2246 Enacted
Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
No summary has been published for this bill. The full text is on the Bill text tab.
- Chamber
- House
- Introduced
- Feb 2, 2026
- Last action
- May 26, 2026 — Pub. Ch. 1016
- Session
- 114
- Momentum
- 84 · Very high